Published in PLoS Med on July 05, 2011
Improving the estimation of influenza-related mortality over a seasonal baseline. Epidemiology (2012) 2.68
Integrating influenza antigenic dynamics with molecular evolution. Elife (2014) 1.80
Influenza forecasting in human populations: a scoping review. PLoS One (2014) 1.66
Excess mortality associated with influenza A and B virus in Hong Kong, 1998-2009. J Infect Dis (2012) 1.54
Comparison of filtering methods for the modeling and retrospective forecasting of influenza epidemics. PLoS Comput Biol (2014) 1.47
Infection fatality risk of the pandemic A(H1N1)2009 virus in Hong Kong. Am J Epidemiol (2013) 1.47
Mortality burden of the 2009 A/H1N1 influenza pandemic in France: comparison to seasonal influenza and the A/H3N2 pandemic. PLoS One (2012) 1.29
Canalization of the evolutionary trajectory of the human influenza virus. BMC Biol (2012) 1.26
Inference of seasonal and pandemic influenza transmission dynamics. Proc Natl Acad Sci U S A (2015) 1.25
Contrasting the epidemiological and evolutionary dynamics of influenza spatial transmission. Philos Trans R Soc Lond B Biol Sci (2013) 1.17
Age- and sex-related risk factors for influenza-associated mortality in the United States between 1997-2007. Am J Epidemiol (2013) 1.11
The contrasting phylodynamics of human influenza B viruses. Elife (2015) 1.10
Modelling estimates of the burden of Respiratory Syncytial virus infection in adults and the elderly in the United Kingdom. BMC Infect Dis (2015) 1.09
Utilizing syndromic surveillance data for estimating levels of influenza circulation. Am J Epidemiol (2014) 1.05
Demonstrating the use of high-volume electronic medical claims data to monitor local and regional influenza activity in the US. PLoS One (2014) 0.99
Phylogenetic and evolutionary history of influenza B viruses, which caused a large epidemic in 2011-2012, Taiwan. PLoS One (2012) 0.98
Flexible Modeling of Epidemics with an Empirical Bayes Framework. PLoS Comput Biol (2015) 0.98
Predictive validation of an influenza spread model. PLoS One (2013) 0.96
Age distribution of influenza like illness cases during post-pandemic A(H3N2): comparison with the twelve previous seasons, in France. PLoS One (2013) 0.95
Targeting imperfect vaccines against drug-resistance determinants: a strategy for countering the rise of drug resistance. PLoS One (2013) 0.90
Forecasting Influenza Epidemics in Hong Kong. PLoS Comput Biol (2015) 0.89
Using extreme value theory approaches to forecast the probability of outbreak of highly pathogenic influenza in Zhejiang, China. PLoS One (2015) 0.88
Exploring a proposed WHO method to determine thresholds for seasonal influenza surveillance. PLoS One (2013) 0.88
Deaths averted by influenza vaccination in the U.S. during the seasons 2005/06 through 2013/14. Vaccine (2015) 0.88
On the relative role of different age groups in influenza epidemics. Epidemics (2015) 0.85
Vaccine allocation in a declining epidemic. J R Soc Interface (2012) 0.85
Pathogen evolution and the immunological niche. Ann N Y Acad Sci (2014) 0.85
The US 2009 A(H1N1) influenza epidemic: quantifying the impact of school openings on the reproductive number. Epidemiology (2014) 0.85
Longevity and determinants of protective humoral immunity after pandemic influenza infection. Am J Respir Crit Care Med (2015) 0.83
Estimates of hospitalization attributable to influenza and RSV in the US during 1997-2009, by age and risk status. BMC Public Health (2017) 0.83
Ten influenza seasons in France: distribution and timing of influenza A and B circulation, 2003-2013. BMC Infect Dis (2015) 0.82
Triggering interventions for influenza: the ALERT algorithm. Clin Infect Dis (2014) 0.82
Influenza-Associated Excess Mortality in South Korea. Am J Prev Med (2015) 0.82
The association of meningococcal disease with influenza in the United States, 1989-2009. PLoS One (2014) 0.79
Mortality attributable to influenza in England and Wales prior to, during and after the 2009 pandemic. PLoS One (2013) 0.79
Quantifying and Mitigating the Effect of Preferential Sampling on Phylodynamic Inference. PLoS Comput Biol (2016) 0.78
Strain Interactions as a Mechanism for Dominant Strain Alternation and Incidence Oscillation in Infectious Diseases: Seasonal Influenza as a Case Study. PLoS One (2015) 0.78
Improved Discrimination of Influenza Forecast Accuracy Using Consecutive Predictions. PLoS Curr (2015) 0.78
National Influenza Surveillance in the Philippines from 2006 to 2012: seasonality and circulating strains. BMC Infect Dis (2016) 0.78
Effect of the one-child policy on influenza transmission in China: a stochastic transmission model. PLoS One (2014) 0.77
Influenza surveillance in Europe: comparing intensity levels calculated using the moving epidemic method. Influenza Other Respir Viruses (2015) 0.77
Coherence of Influenza Surveillance Data across Different Sources and Age Groups, Beijing, China, 2008-2015. PLoS One (2016) 0.75
Associations between Meteorological Parameters and Influenza Activity in Berlin (Germany), Ljubljana (Slovenia), Castile and León (Spain) and Israeli Districts. PLoS One (2015) 0.75
Estimation of influenza-attributable medically attended acute respiratory illness by influenza type/subtype and age, Germany, 2001/02-2014/15. Influenza Other Respir Viruses (2016) 0.75
Forecasting Influenza Outbreaks in Boroughs and Neighborhoods of New York City. PLoS Comput Biol (2016) 0.75
Population effect of influenza vaccination under co-circulation of non-vaccine variants and the case for a bivalent A/H3N2 vaccine component. Epidemics (2017) 0.75
Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA (2003) 31.71
Ecological and immunological determinants of influenza evolution. Nature (2003) 7.60
Absolute humidity and the seasonal onset of influenza in the continental United States. PLoS Biol (2010) 5.43
Protective efficacy of seasonal influenza vaccination against seasonal and pandemic influenza virus infection during 2009 in Hong Kong. Clin Infect Dis (2010) 4.81
Association between the 2008-09 seasonal influenza vaccine and pandemic H1N1 illness during Spring-Summer 2009: four observational studies from Canada. PLoS Med (2010) 3.85
Cross-subtype protection in humans during sequential, overlapping, and/or concurrent epidemics caused by H3N2 and H1N1 influenza viruses. J Infect Dis (1985) 2.86
Yearly influenza vaccinations: a double-edged sword? Lancet Infect Dis (2009) 2.22
Absolute humidity and pandemic versus epidemic influenza. Am J Epidemiol (2010) 2.00
Vaccination against human influenza A/H3N2 virus prevents the induction of heterosubtypic immunity against lethal infection with avian influenza A/H5N1 virus. PLoS One (2009) 1.44
Transmissibility of 1918 pandemic influenza. Nature (2004) 16.14
Seasonality of antibiotic-resistant streptococcus pneumoniae that causes acute otitis media: a clue for an antibiotic-restriction policy? J Infect Dis (2008) 7.76
Serotype replacement in disease after pneumococcal vaccination. Lancet (2011) 7.14
Epochal evolution shapes the phylodynamics of interpandemic influenza A (H3N2) in humans. Science (2006) 6.01
Public health interventions and epidemic intensity during the 1918 influenza pandemic. Proc Natl Acad Sci U S A (2007) 5.90
The severity of pandemic H1N1 influenza in the United States, from April to July 2009: a Bayesian analysis. PLoS Med (2009) 5.86
Estimates of the prevalence of pandemic (H1N1) 2009, United States, April-July 2009. Emerg Infect Dis (2009) 5.56
Absolute humidity and the seasonal onset of influenza in the continental United States. PLoS Biol (2010) 5.43
Recognition of pneumolysin by Toll-like receptor 4 confers resistance to pneumococcal infection. Proc Natl Acad Sci U S A (2003) 4.56
Use of whole genome sequencing to estimate the mutation rate of Mycobacterium tuberculosis during latent infection. Nat Genet (2011) 4.19
Interleukin-17A mediates acquired immunity to pneumococcal colonization. PLoS Pathog (2008) 4.05
Estimation of the reproductive number and the serial interval in early phase of the 2009 influenza A/H1N1 pandemic in the USA. Influenza Other Respir Viruses (2009) 4.02
Geographic diversity and temporal trends of antimicrobial resistance in Streptococcus pneumoniae in the United States. Nat Med (2003) 3.54
Ecological theory suggests that antimicrobial cycling will not reduce antimicrobial resistance in hospitals. Proc Natl Acad Sci U S A (2004) 3.46
Genomic epidemiology of the Escherichia coli O104:H4 outbreaks in Europe, 2011. Proc Natl Acad Sci U S A (2012) 3.42
Continued impact of pneumococcal conjugate vaccine on carriage in young children. Pediatrics (2009) 3.32
CD4+ T cells mediate antibody-independent acquired immunity to pneumococcal colonization. Proc Natl Acad Sci U S A (2005) 3.30
Viral shedding and clinical illness in naturally acquired influenza virus infections. J Infect Dis (2010) 3.29
Weather-based prediction of Plasmodium falciparum malaria in epidemic-prone regions of Ethiopia I. Patterns of lagged weather effects reflect biological mechanisms. Malar J (2004) 3.07
Control-group selection importance in studies of antimicrobial resistance: examples applied to Pseudomonas aeruginosa, Enterococci, and Escherichia coli. Clin Infect Dis (2002) 2.99
Pandemic flu: we are not prepared. MedGenMed (2005) 2.89
Inefficient cytotoxic T lymphocyte-mediated killing of HIV-1-infected cells in vivo. PLoS Biol (2006) 2.81
Mycobacterium tuberculosis mutation rate estimates from different lineages predict substantial differences in the emergence of drug-resistant tuberculosis. Nat Genet (2013) 2.80
Pneumococcal capsular polysaccharide structure predicts serotype prevalence. PLoS Pathog (2009) 2.69
Improving the estimation of influenza-related mortality over a seasonal baseline. Epidemiology (2012) 2.68
Population genomics of post-vaccine changes in pneumococcal epidemiology. Nat Genet (2013) 2.63
Association of serotype with risk of death due to pneumococcal pneumonia: a meta-analysis. Clin Infect Dis (2010) 2.50
Real-time influenza forecasts during the 2012-2013 season. Nat Commun (2013) 2.26
Global migration dynamics underlie evolution and persistence of human influenza A (H3N2). PLoS Pathog (2010) 2.24
Interference between Streptococcus pneumoniae and Staphylococcus aureus: In vitro hydrogen peroxide-mediated killing by Streptococcus pneumoniae. J Bacteriol (2006) 2.22
Antibody-independent, interleukin-17A-mediated, cross-serotype immunity to pneumococci in mice immunized intranasally with the cell wall polysaccharide. Infect Immun (2006) 2.20
Construction of otherwise isogenic serotype 6B, 7F, 14, and 19F capsular variants of Streptococcus pneumoniae strain TIGR4. Appl Environ Microbiol (2003) 2.19
Generation interval contraction and epidemic data analysis. Math Biosci (2008) 2.04
Absolute humidity and pandemic versus epidemic influenza. Am J Epidemiol (2010) 2.00
Beneficial and perverse effects of isoniazid preventive therapy for latent tuberculosis infection in HIV-tuberculosis coinfected populations. Proc Natl Acad Sci U S A (2006) 2.00
Diversity and antibiotic resistance among nonvaccine serotypes of Streptococcus pneumoniae carriage isolates in the post-heptavalent conjugate vaccine era. J Infect Dis (2006) 1.99
Hedging against antiviral resistance during the next influenza pandemic using small stockpiles of an alternative chemotherapy. PLoS Med (2009) 1.99
Oseltamivir and risk of lower respiratory tract complications in patients with flu symptoms: a meta-analysis of eleven randomized clinical trials. Clin Infect Dis (2011) 1.95
Optimizing infectious disease interventions during an emerging epidemic. Proc Natl Acad Sci U S A (2009) 1.92
Modeling community- and individual-level effects of child-care center attendance on pneumococcal carriage. Clin Infect Dis (2005) 1.91
Projected benefits of active surveillance for vancomycin-resistant enterococci in intensive care units. Clin Infect Dis (2004) 1.90
Studies needed to address public health challenges of the 2009 H1N1 influenza pandemic: insights from modeling. PLoS Med (2010) 1.83
Epidemiologic evidence for serotype-specific acquired immunity to pneumococcal carriage. J Infect Dis (2008) 1.72
Apparent declining efficacy in randomized trials: examples of the Thai RV144 HIV vaccine and South African CAPRISA 004 microbicide trials. AIDS (2012) 1.71
Age- and serogroup-related differences in observed durations of nasopharyngeal carriage of penicillin-resistant pneumococci. J Clin Microbiol (2007) 1.68
Antibiotic resistance--the interplay between antibiotic use in animals and human beings. Lancet Infect Dis (2003) 1.67
Cardiac-myocyte-specific excision of the vinculin gene disrupts cellular junctions, causing sudden death or dilated cardiomyopathy. Mol Cell Biol (2007) 1.63
Serum serotype-specific pneumococcal anticapsular immunoglobulin g concentrations after immunization with a 9-valent conjugate pneumococcal vaccine correlate with nasopharyngeal acquisition of pneumococcus. J Infect Dis (2005) 1.61
Comment on "Seroevidence for H5N1 influenza infections in humans: meta-analysis". Science (2012) 1.58
Effects of heterogeneous and clustered contact patterns on infectious disease dynamics. PLoS Comput Biol (2011) 1.53
Impact of more than a decade of pneumococcal conjugate vaccine use on carriage and invasive potential in Native American communities. J Infect Dis (2011) 1.51
Association of the pneumococcal pilus with certain capsular serotypes but not with increased virulence. J Clin Microbiol (2007) 1.51
The analysis of hospital infection data using hidden Markov models. Biostatistics (2004) 1.51
Vaccine production, distribution, access, and uptake. Lancet (2011) 1.49
SpxB is a suicide gene of Streptococcus pneumoniae and confers a selective advantage in an in vivo competitive colonization model. J Bacteriol (2007) 1.48
Single-step capsular transformation and acquisition of penicillin resistance in Streptococcus pneumoniae. J Bacteriol (2004) 1.48
Antibody-independent, CD4+ T-cell-dependent protection against pneumococcal colonization elicited by intranasal immunization with purified pneumococcal proteins. Infect Immun (2007) 1.45
The effect of antiretroviral therapy on secondary transmission of HIV among men who have sex with men. Clin Infect Dis (2007) 1.43
Alert threshold algorithms and malaria epidemic detection. Emerg Infect Dis (2004) 1.42
Pneumococcal carriage and antibiotic resistance in young children before 13-valent conjugate vaccine. Pediatr Infect Dis J (2012) 1.41
Incremental increase in fitness cost with increased beta -lactam resistance in pneumococci evaluated by competition in an infant rat nasal colonization model. J Infect Dis (2006) 1.40
Niche and neutral effects of acquired immunity permit coexistence of pneumococcal serotypes. Science (2012) 1.39
Protection against nasopharyngeal colonization by Streptococcus pneumoniae is mediated by antigen-specific CD4+ T cells. Infect Immun (2008) 1.39
Quantifying interhospital patient sharing as a mechanism for infectious disease spread. Infect Control Hosp Epidemiol (2010) 1.39
Student behavior during a school closure caused by pandemic influenza A/H1N1. PLoS One (2010) 1.38
Serotype specific invasive capacity and persistent reduction in invasive pneumococcal disease. Vaccine (2010) 1.37
Impaired innate and adaptive immunity to Streptococcus pneumoniae and its effect on colonization in an infant mouse model. Infect Immun (2009) 1.35
Antibodies to conserved pneumococcal antigens correlate with, but are not required for, protection against pneumococcal colonization induced by prior exposure in a mouse model. Infect Immun (2005) 1.35
The prevalence and risk factors for pneumococcal colonization of the nasopharynx among children in Kilifi District, Kenya. PLoS One (2012) 1.34
Use of cumulative incidence of novel influenza A/H1N1 in foreign travelers to estimate lower bounds on cumulative incidence in Mexico. PLoS One (2009) 1.33
Improving influenza vaccine virus selection: report of a WHO informal consultation held at WHO headquarters, Geneva, Switzerland, 14-16 June 2010. Influenza Other Respir Viruses (2011) 1.32
Mechanisms by which antibiotics promote dissemination of resistant pneumococci in human populations. Am J Epidemiol (2005) 1.31
What is the mechanism for persistent coexistence of drug-susceptible and drug-resistant strains of Streptococcus pneumoniae? J R Soc Interface (2009) 1.30
Carried pneumococci in Massachusetts children: the contribution of clonal expansion and serotype switching. Pediatr Infect Dis J (2011) 1.28
Pandemic influenza: risk of multiple introductions and the need to prepare for them. PLoS Med (2006) 1.26
The pneumococcal pilus predicts the absence of Staphylococcus aureus co-colonization in pneumococcal carriers. Clin Infect Dis (2009) 1.23
Age-specific immunoglobulin g (IgG) and IgA to pneumococcal protein antigens in a population in coastal kenya. Infect Immun (2004) 1.22
Oseltamivir for treatment and prevention of pandemic influenza A/H1N1 virus infection in households, Milwaukee, 2009. BMC Infect Dis (2010) 1.21
Comparative genomics of recent Shiga toxin-producing Escherichia coli O104:H4: short-term evolution of an emerging pathogen. MBio (2013) 1.19
Little evidence for genetic susceptibility to influenza A (H5N1) from family clustering data. Emerg Infect Dis (2007) 1.17
The El Nino-Southern Oscillation (ENSO)-pandemic influenza connection: coincident or causal? Proc Natl Acad Sci U S A (2012) 1.17
The severity of pandemic H1N1 influenza in the United States, April -- July 2009. PLoS Curr (2009) 1.15
Strength and tempo of selection revealed in viral gene genealogies. BMC Evol Biol (2011) 1.15
Secular trends in Helicobacter pylori seroprevalence in adults in the United States: evidence for sustained race/ethnic disparities. Am J Epidemiol (2011) 1.13
Re-emergence of the type 1 pilus among Streptococcus pneumoniae isolates in Massachusetts, USA. Vaccine (2010) 1.12
Epidemiology and risk factors for Staphylococcus aureus colonization in children in the post-PCV7 era. BMC Infect Dis (2009) 1.11
Age- and sex-related risk factors for influenza-associated mortality in the United States between 1997-2007. Am J Epidemiol (2013) 1.11
Rates of acquisition and clearance of pneumococcal serotypes in the nasopharynges of children in Kilifi District, Kenya. J Infect Dis (2012) 1.11
Cholera modeling: challenges to quantitative analysis and predicting the impact of interventions. Epidemiology (2012) 1.10
Prediction of serotypes causing invasive pneumococcal disease in unvaccinated and vaccinated populations. Epidemiology (2011) 1.09
Using pneumococcal carriage data to monitor postvaccination changes in invasive disease. Am J Epidemiol (2013) 1.09
Serum antipneumococcal antibodies and pneumococcal colonization in adults with chronic obstructive pulmonary disease. J Infect Dis (2007) 1.09
Projection of the future dimensions and costs of the genital herpes simplex type 2 epidemic in the United States. Sex Transm Dis (2002) 1.06
Utilizing syndromic surveillance data for estimating levels of influenza circulation. Am J Epidemiol (2014) 1.05
Time from illness onset to death, 1918 influenza and pneumococcal pneumonia. Emerg Infect Dis (2009) 1.00
Absolute humidity and the seasonal onset of influenza in the continental US. PLoS Curr (2009) 1.00